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ABSTRACT
Background: Although supporting lifestyle change is
an effective way of preventing further events in people
with cardiovascular disease, providing access to such
interventions is a major challenge. This study aims to
investigate whether simple reminders about behaviour
change sent via mobile phone text message decrease
cardiovascular risk.
Methods and analysis: Randomised controlled trial
with 6 months of follow-up to evaluate the feasibility,
acceptability and effect on cardiovascular risk of
repeated lifestyle reminders sent via mobile phone text
messages compared to usual care. A total of 720
patients with coronary artery disease will be
randomised to either standard care or the TEXT ME
intervention. The intervention group will receive
multiple weekly text messages that provide
information, motivation, support to quit smoking (if
relevant) and recommendations for healthy diets and
exercise. The primary end point is a change in plasma
low-density lipoprotein cholesterol at 6 months.
Secondary end points include a change in systolic
blood pressure, smoking status, quality of life,
medication adherence, waist circumference, physical
activity levels, nutritional status and mood at
6 months. Process outcomes related to acceptability
and feasibility of TEXT ME will also be collected.
Ethics and dissemination: Primary ethics approval
was received from Western Sydney Local Health
Network Human Research Ethics
CommitteedWestmead. Results will be disseminated
via the usual scientiﬁc forums including peer-reviewed
publications and presentations at international
conferences.
Clinical trials registration
number: ACTRN12611000161921.
INTRODUCTION
Cardiovascular disease (CVD), including
coronary heart disease (CHD) and stroke, is
the leading cause of death and disease
burden globally.
1 Secondary prevention
strategies that target individuals at the
highest risk with proven treatments are
theoretically the most effective and efﬁcient
means of preventing cardiovascular events.
2
However, surveys indicate poor utilisation of
secondary prevention and in particular poor
adherence to lifestyle recommendations.
34
In a recent sample of 18809 patients, from 41
countries, following an acute coronary
syndrome (ACS), only about 30% of patients
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ARTICLE SUMMARY
Article focus
- The article provides the rationale and protocol for
a randomised controlled trial to test the efﬁcacy
of mobile phone text message reminders to
promote behaviour change and reduce cardiac
risk in patients with coronary heart disease.
Key messages
- Mobile phone text messages may potentially be
a cheap, safe and simple way to promote healthy
behaviour, improve mood and increase compli-
ance with cardiac medication. This in turn would
reduce cardiovascular risk. The effectiveness of
this approach needs to be tested in well-designed
and rigorously conducted clinical trials.
Strengths and limitations of this study
- The main strengths of the current study are that
it uses a simple and inexpensive text message-
based programme that is suitable for widespread
use and will test this strategy in a randomised,
controlled and blinded study. The study is,
however, being conducted in only Australian
tertiary centres and, therefore, the generalis-
ability is somewhat limited, although the cohort
size is relatively large.
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Open Access Protocolreported adhering to diet and exercise recommenda-
tions and only about two-thirds of patients reported
quitting smoking in the 6 months after their event.
5
Meta-analyses have demonstrated the beneﬁts and
effectiveness of lifestyle modiﬁcation through a wide
variety of secondary prevention programmes. In meta-
regression analysis of 63 randomised trials including
21295 patients, secondary prevention programmes
reduced mortality and recurrent heart attack by 15%e
20%.
6 Effects were similar for programmes that included
risk factor education or counselling with or without
a structured exercise component.
6 Effects were also
similar in shorter versus longer programmes,
programmes based on general practice versus hospital-
based programmes and in programmes staffed by
generalists versus specialists.
2
Unfortunately, despite the efﬁcacy of these
programmes, there is substantial underutilisation of
existing programmes internationally. In the USA,
4 UK
3
and Australia,
78only about a third of eligible patients
participate in cardiac rehabilitation. Furthermore, non-
attendees are at higher baseline risk and have poorer
risk factor knowledge than those accessing rehabilita-
tion.
9 These challenges have resulted in the develop-
ment and testing of a wide range of alternative cardiac
rehabilitation models (now becoming known as
secondary prevention programmes) over the past
10 years. These, more contemporary programmes,
involve in isolation or combination, in-person visits,
community services and home manuals with phone/
electronic support for ﬂexible and individualised
management of CHD.
6 A recent systematic review also
found that ‘telehealth’ secondary prevention interven-
tions (including programmes delivered via telephone,
internet or videoconferencing) provide effective CVD
risk factor reduction.
10 However, there has been limited
success in the translation of these programmes from trial
to clinical practice and minimal data on feasibility.
Overall, there is good evidence that secondary
prevention programmes aimed at modifying health
behaviours including smoking, exercise and diet are
effective, but they are consistently underutilised. The
complexity, number and diversity of available
programmes also raise concerns that they may be difﬁ-
cult to replicate cheaply in different settings. In addi-
tion, despite evidence that depressed mood may impair
a patient’s response to behaviour change or medical
adherence, very few secondary prevention programmes
describe mood or depression as a focus of manage-
ment.
11 Ultimately, there is unlikely to be one perfect
programme. Therefore, more exploration is required
regarding simple methods to enhance currently effective
programmes.
Mobile or cellular telephones are a valuable and widely
accessible form of quick and cheap communication
and are potentially an ideal means of providing rein-
forcement messages for supporting lifestyle change.
Increasing numbers of people across all income, age and
ethnic groups own a mobile phone. In 2008, there
were over 4 billion active mobile phone subscribers
globally.
12 Importantly, studies indicate mobile phone
use is greater among disadvantaged populations where
more frequent mobile phone use is associated with lower
education, socioeconomic status
13 and poorer health.
14
Also, while mobile phone ownership is the highest
among 18e24-year-olds, trends show increasing owner-
ship for all age groups and the largest annual increase in
mobile phone ownership among the over 65-year age
group.
15
The delivery of short messages to mobile phones using
Short Message Service (SMS), also known as text
messaging, is a common, convenient, rapid and cheap
method of communication globally. The international
technology consulting ﬁrm Ovum estimates approxi-
mately 1.25 trillion SMS messages were sent globally in
2005.
15 A few recent studies have evaluated the effec-
tiveness of mobile phone text messaging to change
individual health behaviours, including smoking, weight
loss and physical activity or to improve the medical
management of diabetes
16 or adherence to medica-
tion.
17 However, no known trial to date has addressed
multiple risk factors for CVD management. Reducing
multiple risk factors concurrently, rather than targeting
single factors is likely to deliver greater reduction in
events.
18 A recent systematic review of behaviour change
interventions delivered by mobile phone text messages
identiﬁed 14 relevant studies from peer-reviewed
journals in English.
19 The authors reported that SMS-
delivered interventions had positive short-term behav-
ioural outcomes. However, a number of studies were of
poor quality as most had limited statistical power and no
process outcomes.
Only a few studies are sufﬁciently large enough or
powered to effectively examine the effect size of SMS
interventions.
20e22 A recent Cochrane review of 1905
participants summarised the results for smoking.
20 The
majority of participants from this review was from one
trial of a SMS-only intervention study that included
a total of 1905 smokers and found that those receiving
interventions were approximately twice as likely to quit
smoking in the short term (RR 2.18, 95% CI 1.80 to
2.65). The randomised controlled trial evidence exam-
ining effects on weight or physical activity are consider-
ably smaller than that for smoking cessation.
21 22
Overall, while there is some evidence around the beneﬁt
of SMS for facilitating behaviour change for individual
risk factors, there are no known studies investigating the
role of SMS in managing multiple risk factors in people
with CVD. Therefore, the primary objective of this study
was to determine the impact of a programme of lifestyle
information, motivation and support sent via mobile
phone text messages on cardiovascular risk factors,
quality of life and mood in a population of patients with
known CHD. In addition, this study will investigate the
acceptability, feasibility cost-effectiveness of delivering
a SMS-based intervention in this setting.
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TEXT ME for cardiovascular disease preventionMETHODS AND ANALYSIS
Design
TEXT ME is a single-blind randomised controlled trial
with 6 months of follow-up (ﬁgure 1) (ACTRN12611
000161921). The study will be conducted at two large
metropolitan tertiary referral public hospitals in
Australia that serve an ethnically, culturally and socio-
economically diverse population. A total of 720 patients
admitted to hospital with an ACS or evidence of coro-
nary artery disease on coronary angiogram will be
included. Participants will be randomly allocated to
either the control or intervention group. The control
group will participate in standard care and the inter-
vention group will participate in the TEXT ME
programme and will receive behaviour change
reminders via SMS text message in addition to standard
care. Blinded assessments will be conducted at baseline
and 6 months during a face-to-face interview.
Randomisation
Randomisation will occur via a computerised random-
isation program that will be accessible by study staff with
username and password through a web interface. The
random allocation sequence will be in a uniform 1:1
(control:intervention) allocation ratio and will be
concealed from study personnel until the completion of
the trial. Study personnel taking follow-up assessments
will also be blinded to parallel group assignments.
Study population
Patients admitted to tertiary referral hospitals, in Sydney
Australia, over a 24-month period with documented
CHD will be eligible for the study. These patients are at
high risk of future cardiovascular events and are likely to
be motivated to change their lifestyle. Patients will be
eligible if they have been admitted to hospital with an
ACS and/or have angiographically conﬁrmed coronary
artery disease (>50% stenosis in a least one major vessel)
(identiﬁed during inpatient admission or though
outpatient clinics), if they provide informed consent,
have an operational mobile telephone and have sufﬁ-
cient English language skills to provided informed
consent and understand the text messages. For those
people who are ineligible or decline to participate,
we will keep a ‘screening log’ of basic demographic
information and reasons for non-participation.
Interventions
The control group will receive ongoing standard care for
their cardiovascular health, including pharmacotherapy
and lifestyle counselling as determined by their usual
doctors. The TEXT ME intervention group will receive
ongoing standard care as well as regular text messages
via SMS over a 6-month period. These messages will be
unidirectional and will serve as reminders but will not
allow two-way communication with a researcher or
health professional about clinical management. The
messages will provide advice, motivation, information
Figure 1 Study design and ﬂow. ACS, acute coronary
syndrome; CAD, coronary artery disease; CV, cardiovascular.
Box 1 Examples of messages sent to the TEXT ME
intervention group
General cardiovascular health and medications
- Check out http://www.heartfoundation.org.au for tips and
info about preventing heart disease
- Are you taking daily aspirin? If not discuss it with your Dr
- Not having support of family and friends can worsen
heart diseasedif you need help, don’t be afraid to ask
- Rememberdcholesterol and blood pressure lowering
tablets need to be taken every day
Nutrition
- Healthy eating means at least ﬁve serves of vegetables
and two serves of fruit every day
- Try bananas for an easy and nutritious sandwich ﬁlling
- To add interest to your meals try a new fruit, vegetable or
herb
- Try steaming, baking or BBQ to reduce the need for
excess oil when cooking
Physical activity
- Keep a calendar of how often you walk
- Begin activity at low intensity and gradually increase
- There are many ways to increase your activity levels. Try
Tai Chi, pilates, gardening, yoga or dancing
- The more you eat the more you need to exercise
Smoking
- Its never too late to quit smoking
- It may take several attempts to quit, so keep trying
- If you crave a cigarette try and distract yourself by going
for a walk or doing something creative
- Check out the website http://www.icanquit.com.au for
tips and to track your progress when quitting smoking
BBQ, barbeque.
Chow CK, Redfern J, Thiagalingam A, et al. BMJ Open 2012;2:e000606. doi:10.1136/bmjopen-2011-000606 3
TEXT ME for cardiovascular disease preventionand support to quit smoking (if relevant) and engage in
healthy diets and exercise (box 1) and will reinforce the
initial advice and counselling received in hospital.
Participants will not be expected or asked to respond to
text messages they receive. All participants will be
offered brief training at enrolment on how to read a text
message and how to delete or save messages. All partic-
ipants will be provided with the contact details of
research personnel and contacted at least once during
the intervention period to facilitate follow-up. A
researcher will manage a mobile telephone that will
receive any messages received from the participant’s
phones. This researcher will not participate in any indi-
vidual level of analysis and will keep a record of all
messages received from participants throughout the
course of the study. Participants will have the opportu-
nity to withdraw via a text message and the researcher
will contact the software manager in order to activate the
withdrawal. If the TEXT ME mobile phone receives
a messages indicating that a participants mailbox is full,
the researcher will contact the participant to discuss but
will not provide any medical advice.
TEXT ME intervention development
A ‘bank’ of 100 text messages have been systematically
developed through an iterative process and based on
current national guidelines.
23 The messages are cate-
gorised into four groups including (1) general heart
health information messages that include facts about
CVD and information about medications and risk
factors, (2) nutrition messages, (3) physical activity
messages and (4) smoking cessation messages (box 1).
Each message is <160 characters and is suitable for
people of any age or gender.
The initial ‘bank’ of draft messages was scrutinised and
modiﬁed by an expert review panel made up of a multi-
disciplinary group of clinicians (including cardiologists,
a psychologist, a physiotherapist, nurses and public
health specialists), researchers and academics. The ﬁnal
draft bank of text messages was then evaluated by 53
consumers completing a qualitative questionnaire. This
survey asked for comment and feedback about useful-
ness and understanding for speciﬁc text messages.
Feedback from the surveys was then addressed and
a ﬁnal ‘bank’ of messages was prepared ready for use in
the TEXT ME intervention.
Frequency, sequence and management of text message
delivery
Each participant in the TEXT ME intervention group
will receive four messages per week for 24 weeks. These
will be sent at one of four random times (9:00, 12:00,
15:00, 17:00) and on four of ﬁve random week days.
Non-smokers will receive one general heart health and
medication messages, one nutritional message, one
physical activity message and one random message from
one of the above groups per week. Smokers will receive
one general heart health and medication message, one
nutritional message, one physical activity message and
one smoking cessation message per week. Messages will
include the recipients preferred name and will be
received in random order, and no message will be
repeated. Prior to commencement, a semi-personalised
test SMS will be sent to each participant to ensure the
correct telephone number has been recorded and that
the system is working effectively.
The management of message delivery will be by the
TEXT ME software program. This is a speciﬁcally
designed, computerised software messaging engine
developed by programmers with input from the research
team.
24 25 The software program has an entry page to
input speciﬁcations such as start and end date, mobile
phone number and inclusion/exclusion of smoking
cessation messages. The program will keep a log of all
messages sent to each study participant and those which
fail to be delivered. The messaging engine will send
messages through a gateway interface to enable them to
be sent to all participants on any Australian phone
network at no cost to the participant and at a bulk-rate
cost to the study. Data exports will be compliant with
privacy legislation, centrally managed by the George
Institute and held in strict conﬁdence. There will be no
access to these data by any third party, including the
software developers.
Study outcomes
The primary outcome of the study is change in low-
density lipoprotein (LDL) cholesterol level as measured
by fasting blood sample (box 2). Secondary outcomes
are change in other biomedical risk factors, behavioural
risk factors, quality of life and depression (box 2). In
addition, we will monitor participants for myocardial
infarction, stroke, death or any re-hospitalisation.
Patients will be followed up at 6 months at a face-to-face
interview with a research assistant who will be blinded to
Box 2 Primary and secondary outcomes (measured at
baseline and 6 months)
Primary
- Low-density lipoprotein cholesteroldfasting blood
sample
Secondary
- Body mass index and waist circumferencedmeasured
by researcher blinded to treatment allocation
- Systolic blood pressuredthree resting, sitting digital
recordings, mean of last two readings
26
- Physical activitydGlobal Physical Activity Question-
naire
27
- Smoking rate, quitting attemptsdself-report, carbon
monoxide metre
28
- Fruit/ vegetable intakedself-report of portions consumed
in prior 7 days
- Psychosocial factorsdSF-12 Health Survey
29 and
Patient Health Questionnaire-9 depression scale
30
- Combined riskdabsolute number of modiﬁable risk
factors
- Cardioprotective medication usedself-report
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TEXT ME for cardiovascular disease preventiontreatment allocation (ﬁgure 1). Self-reported smoking
cessation will be conﬁrmed with an Airmet Scientiﬁc
Micro Plus Smokerlyzer (carbon monoxide metre breath
test where a reading of >8 represents recent tobacco
smoking).
28 Physical activity will be assessed via the
Global Physical Activity Questionnaire.
27 The Global
Physical Activity Questionnaire was developed by the
WHO and collects information on physical activity
participation in three domains (activity at work, travel to
and from places, recreation) as well as sedentary
behaviour, comprising 16 questions. Quality of life will
be measured using the 12-item short form (SF-12) health
survey
29 and depression via the Patient Health Ques-
tionnaire-9. The Patient Health Questionnaire-9 is
a nine-item depression scale, which scores each of the
nine Diagnostic and Statistical Manual of Mental Disor-
ders IV criteria as ‘0’ (not at all) to ‘3’ (nearly every day)
generating a total score from 0 to 27.
30
Process measures
For process measures, we will keep a log of the level of
competence with text messaging of participants at study
entry and thus the requirement for text message
training. Logs will be kept to assess the time messages are
sent and the proportion of text messages successfully
delivered (eg, if mobile phone mail boxes are full). A log
will be kept of how many participants contact the study
team, the reason for contact and the method used for
contact (eg, by telephone, email).
To examine acceptability and feasibility of TEXT ME,
participants allocated to the intervention group will also
be administered an additional questionnaire, after the
blinded 6-month follow-up assessment. The question-
naire will include items that address the acceptability of
repeated text messages, identiﬁcation of which messages
participants remembered, liked or disliked, what they
did with messages (eg, kept them or deleted them
immediately), their perceived utility of the text message
and their opinion regarding the intrusiveness, timing
and content suitability of the text messages. At follow-up,
information will be recorded about attendance at
a secondary prevention programme such as cardiac
rehabilitation and approximate frequency of visits to
healthcare provider(s).
To obtain a more in-depth understanding of the
potential barriers and facilitators at the service delivery
and individual level to uptake of this programme, we will
also conduct semistructured interviews with a subsample
of participants in the intervention group. Recruitment
for the interviews will be purposive to maximise variation
such as urban/rural location, practice size and degree of
participation for providers; and location, gender and age
for patients. Sampling will continue until no new themes
or categories emerge from the data (the so-called
thematic saturation).
31 We anticipate from previous
experience the need to conduct approximately 40
patient interviews. The interviews will be conducted face-
to-face by a project ofﬁcer with experience in qualitative
interviews. Where appropriate, interviews will be peer-to-
peer. Participants will be asked whether they liked the
program, perceived it to be effective, whether the
program language was appropriate and understandable,
which messages they remembered, liked or disliked,
their perception of the intrusiveness, timing and
content. Interviews will be digitally recorded and tran-
scribed. Interview transcripts and socio-demographic
data will be entered as a project in NVIVO (QSR
NVIVO7, Doncaster, Australia), a program for managing
and analysing qualitative data. The NVIVO software
enables multilevel coding of text against a set of identi-
ﬁed analytical categories. The study team will use an
iterative process to understand the themes and key issues
arising from the data.
Economic analysis
The expected change to economic costs and health
outcomes from widespread adoption of the TEXT ME
intervention will be estimated with cost-effectiveness
analysis. A health sector perspective will be adopted and
values collected for variables that describe the partici-
pant’s use of acute and primary care health services. A
number of brief questions will be included in the data
collection, and consent will also be sought for access to
individual participant Medical Beneﬁts Schedule and
Pharmaceutical Beneﬁts Scheme claims usage through
Medicare Australia to ascertain use of medical services
(GP, specialists and non-hospital diagnostic tests) and
prescribed pharmaceuticals. These costs will be valued
using market prices, or shadow prices will be imputed.
The costs of delivering the intervention will be assessed
by measuring and valuing the incremental resources
used.
32 Changes to health beneﬁts will be assessed using
quality-adjusted life-years. They will be assessed at each
data collection point using the SF-12 Health Survey and
converted to short form 6-dimension (SF-6D) utility
values via an algorithm developed by Brazier and
colleagues.
33 Although we do not expect signiﬁcant
differences in survival or quality of life between treatment
groups within trial, these data are needed to provide an
estimate of the baseline quality of life in this patient
population. A non-signiﬁcant difference in mean health
beneﬁts has great value for estimation studies because
making a decision with uncertainty, rather than testing
a hypothesis, is the goal. Given the likely small numbers
of CVD events occurring within the trial, the quality of life
and costs data collected in-trial will need to be augmented
by data on quality of life and cost associated with CVD
events and associated outcomes derived from literature
review.
34 35 Longer terms costs and quality-adjusted life-
years will be modelled using a decision analytic Markov
model. The advantage of using the Markov model is that
we can extrapolate beyond the data collection period and
describe longer term costs and beneﬁts of the interven-
tion. While this method enables longer term costs and
outcomes of the intervention to be forecast, the decision
uncertainty will increase. To appropriately quantify
uncertainty, Monte Carlo re-samples will be drawn from
probability distributions speciﬁed for all model
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TEXT ME for cardiovascular disease preventionparameters. Cost-effectiveness acceptability curves will be
plotted and used to inform the adoption decision. The
expected value of perfect and partial information will be
estimated to inform future data collection. Plausible
values for discount rates will be used.
Statistical considerations
Intention-to-treat principle will be followed, and char-
acteristics will be compared between the groups at
6-month follow-up using independent t tests for contin-
uous variables (LDL, body mass index, systolic blood
pressure and physical activity) or c
2 tests for categorical
variables (smoking status, combined risk and medication
use) as appropriate. ManneWhitney U tests will be used
where data are not normally distributed. The mean level
of each risk factor between groups will also be compared
in terms of relative risks, 95% CIs and two-sided p values
for achieving the guideline level of each risk factor.
Sample size calculations are focused on difference in
objective measures of outcomes between intervention
and control groups. All calculations are for 90% power
with a two-sided a and assume a ratio of 1:1 for inter-
vention to control subjects. Mean and SD for the
controls are based on that reported by the normal care
arm of the Australian COACH study on lipid levels.
36 To
test for a difference of 0.25 mmol/l in LDL cholesterol
(assuming a mean in control arm of 2.94 mmol/l, SD
0.96 mmol/l), we would require a sample size of 634,
rising to 704 allowing for a 10% loss to follow-up.
ETHICS AND DISSEMINATION
The ﬁndings of this study will be disseminated via the
usual scientiﬁc forums, including peer-reviewed publi-
cations and presentations at international conferences.
The study will be administered by the George Institute,
with the design and conduct overseen by a project
management committee (authors). This committee
has expertise in large-scale clinical trials and qua-
litative research, economic analysis, clinical CVD
management and healthy policy implementation. This
study will adhere to the National Health and Medical
Research Council ethical guidelines for human
research. Formal ethical approval for this study has
been obtained from Western Sydney Local Health
Network Human Research Ethics Committee (West-
mead). Written and informed consent will be obtained
from all participants.
CONCLUSIONS
This study will evaluate an innovative means of reducing
cardiovascular risk factors in individuals at high risk of
having a heart attack or stroke by using cheap and widely
used mobile phone text messaging technology. Only
a few studies exist testing the use of mobile phone text
messages to modify single cardiovascular risk factors,
such as smoking. No known studies have previously
evaluated the acceptability, feasibility and efﬁcacy of
a text message-delivered intervention for addressing
multiple cardiovascular risk factors in persons with
established disease. Therefore, the present study will be
the ﬁrst to provide reliable data about the effectiveness
of a text message intervention for managing multiple
cardiovascular risk factors.
While there is clear evidence that secondary preven-
tion strategies are often effective,
6 there is also clear
evidence that they are commonly underutilised.
348
Mobile phone interventions that are simple, inexpensive
and use current technology could potentially be a useful
complement to existing prevention programmes. Ulti-
mately, this would enable the delivery of advice
regarding CVD prevention to greater numbers of
people, including those in resource poor settings and in
geographically isolated communities. The potential
value of a text-message-delivered intervention could be
great as it could be easily expanded to reach many
mobile phone users at a relatively low cost.
Overall, a number of questions remain about the
feasibility and efﬁcacy of text message-based intervention
programmes, particularly in men or older age groups
who have greater cardiovascular risk. A rigorous study is
needed to evaluate the effectiveness of this intervention
and following this, its cost-effectiveness. In addition, the
content, level of personalisation, frequency of text
messages sent and level of interaction between message
sender and receiver varies greatly between studies, and
it is unclear from prior research what characteristics
of text messages or text message-based intervention
programmes are optimal. The current study will explore
some of these important issues.
In conclusion, TEXT ME will test the utility of a text
messaging-based intervention to reduce cardiovascular
risk factors in patients with known CHD. This strategy
has enormous potential as a cheap, safe and simple
method to improve uptake and adherence to behaviour
change and ultimately improve cardiovascular risk in
millions of people with mobile telephones. However, its
effectiveness must be proven in well-designed and
rigorously conducted clinical trials.
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